Search research articles
Contact Us
Filters
Showing results (151-160 of 760) with videos related to
Page
of 76
Sort By:
Expert Review of Cardiovascular Therapy
|
July 1, 2011
Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus
Dominick J Angiolillo, Marco Roffi, Antonio Fernandez-Ortiz
Expert Review of Cardiovascular Therapy
|
April 22, 2009
Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
Piera Capranzano, Jose Luis Ferreiro, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy
|
October 10, 2009
Cangrelor: a review on its mechanism of action and clinical development
José Luis Ferreiro, Masafumi Ueno, Dominick J Angiolillo
Thrombosis and Haemostasis
|
March 19, 2024
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity
Luis Ortega-Paz, Francesco Franchi, Dominick J Angiolillo
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 20, 2025
Reply: Sex-Related Variations in Platelet Reactivity
Mattia Galli, Dominick J Angiolillo, Fabio M Pulcinelli
European Heart Journal
|
September 7, 2011
Current concepts on coronary revascularization in diabetic patients
Marco Roffi, Dominick J Angiolillo, A Pieter Kappetein
Future Cardiology
|
June 2, 2011
Antiplatelet drug therapy: role of pharmacodynamic and genetic testing
Antonio Tello-Montoliu, Masafumi Ueno, Dominick J Angiolillo
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 2, 2022
Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19
Luis Ortega-Paz, Mattia Galli, Dominick J Angiolillo
Expert Opinion on Investigational Drugs
|
October 29, 2010
Inhibiting PAR-1 in the prevention and treatment of atherothrombotic events
Salvatore Davide Tomasello, Dominick J Angiolillo, Shinya Goto
Journal of Cardiovascular Development and Disease
|
October 26, 2022
P2Y<sub>12</sub> Inhibitor Monotherapy after Percutaneous Coronary Intervention
Xuan Zhou, Dominick J Angiolillo, Luis Ortega-Paz
Page
of 76
Search research articles
Search
Showing results (151-160 of 760) with videos related to
Sort By:
Page
of 76
Expert Review of Cardiovascular Therapy
|
July 1, 2011
Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus
Dominick J Angiolillo, Marco Roffi, Antonio Fernandez-Ortiz
Expert Review of Cardiovascular Therapy
|
April 22, 2009
Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
Piera Capranzano, Jose Luis Ferreiro, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy
|
October 10, 2009
Cangrelor: a review on its mechanism of action and clinical development
José Luis Ferreiro, Masafumi Ueno, Dominick J Angiolillo
Thrombosis and Haemostasis
|
March 19, 2024
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity
Luis Ortega-Paz, Francesco Franchi, Dominick J Angiolillo
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 20, 2025
Reply: Sex-Related Variations in Platelet Reactivity
Mattia Galli, Dominick J Angiolillo, Fabio M Pulcinelli
European Heart Journal
|
September 7, 2011
Current concepts on coronary revascularization in diabetic patients
Marco Roffi, Dominick J Angiolillo, A Pieter Kappetein
Future Cardiology
|
June 2, 2011
Antiplatelet drug therapy: role of pharmacodynamic and genetic testing
Antonio Tello-Montoliu, Masafumi Ueno, Dominick J Angiolillo
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 2, 2022
Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19
Luis Ortega-Paz, Mattia Galli, Dominick J Angiolillo
Expert Opinion on Investigational Drugs
|
October 29, 2010
Inhibiting PAR-1 in the prevention and treatment of atherothrombotic events
Salvatore Davide Tomasello, Dominick J Angiolillo, Shinya Goto
Journal of Cardiovascular Development and Disease
|
October 26, 2022
P2Y<sub>12</sub> Inhibitor Monotherapy after Percutaneous Coronary Intervention
Xuan Zhou, Dominick J Angiolillo, Luis Ortega-Paz
Page
of 76